MEDICAL TESTS EXPLAINED · WHAT YOUR RESULTS MEAN

Prostate-Specific Antigen (PSA)

The PSA test is probably the most debated blood test in men's health. It can detect prostate cancer early, and it also rises for entirely benign reasons, which has made it the textbook case of a screening test with both benefits and harms. This page explains what PSA measures, why there is no simple normal-versus-cancer cutoff, what temporarily distorts it, and what a raised result actually triggers today.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Medical Tests Explained is part of the MedicalVideos.com education program, bridging the Lab Values reference ranges and the Imaging Explained hub. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: A prostate protein in the blood that rises with enlargement, inflammation, and cancer alike — useful for risk sorting and monitoring, never a yes-or-no cancer test.

The guide

What it measures

Prostate-specific antigen is a protein made by prostate gland cells — normal and cancerous alike — that leaks into the blood in small amounts. The PSA blood test measures that level. It entered practice as a monitoring test for men already treated for prostate cancer, where a rising level can signal recurrence, and it is also used, controversially, as a screening test in men without symptoms. Its central limitation defines everything about it: PSA rises with prostate enlargement, inflammation, and infection as readily as with cancer, so it sorts men into risk groups rather than diagnosing or excluding cancer.

How the test is done

PSA is a simple blood draw with no fasting required. Because levels are temporarily raised by ejaculation, vigorous cycling, urinary infection, and prostate examination or procedures, testing is best done away from those influences, and an unexpected result is normally repeated after several weeks before anything else happens. Laboratories may also report a free-to-total PSA ratio, which refines risk slightly — cancer is associated with a lower free fraction. In men on active surveillance or after treatment, the trend and doubling time of PSA over repeated measurements carry more meaning than any single value.

What the results can mean

Interpretation is by pattern and context, not a single cutoff — there is no PSA level below which cancer is impossible or above which it is certain. Levels rise with age as prostates enlarge, so age-adjusted thinking is standard. A confirmed, rising PSA increases the probability of prostate cancer and, more importantly, of clinically significant cancer, which is what modern pathways aim to detect. The screening debate exists because PSA testing reduces prostate cancer deaths modestly while leading some men to biopsies and treatment for cancers that would never have harmed them. That balance is why guidelines present screening as a personal decision to discuss, particularly between the mid-fifties and late sixties, and earlier for men at higher inherited or ethnic risk.

What can distort results — and follow-up

The distorters are everyday: benign prostate enlargement (the commonest cause of a raised PSA in older men), prostatitis, a urinary tract infection, a recent prostate biopsy or surgery, a urinary catheter, and even a digital rectal examination performed just before the draw. Two widely used medicines — finasteride and dutasteride — lower PSA by about half, and failure to account for that can hide a rising trend. A raised PSA today is usually followed by repeat testing, a risk calculator, and often an MRI of the prostate before biopsy is considered, a pathway designed to find significant cancers while avoiding biopsy and overdiagnosis of indolent ones. Any man with a raised PSA plus bone pain, weight loss, or difficulty urinating needs prompt follow-up; urinary retention is an emergency.

Common questions

Does a high PSA mean prostate cancer?

No. PSA is prostate-specific, not cancer-specific: enlargement of the prostate (very common with age), prostatitis, urinary infection, and even recent ejaculation or a long bike ride can raise it. Many men with a raised PSA have no cancer, and some cancers occur at low PSA levels — which is why a raised result starts a process rather than giving an answer.

What happens after a raised PSA?

Often a repeat PSA first, because levels bounce and temporary causes are common. If it stays raised, the modern pathway usually adds risk calculators or a prostate MRI before any biopsy, which targets biopsies to men most likely to have significant cancer and spares many men the procedure.

Who should consider PSA testing?

Guidelines generally frame PSA screening as an individual decision for men in their fifties to late sixties, earlier for those at higher risk — Black men and men with a strong family history among them. Testing is generally not recommended at ages where other health issues limit life expectancy, because the harms of overdiagnosis then outweigh the benefit.

Can medicines lower PSA?

Yes — finasteride and dutasteride, used for prostate enlargement and hair loss, lower PSA by roughly half after months of use. The laboratory value has to be mentally doubled for interpretation, so always tell the clinician who ordered the test if you take one of them.

More in Urine, Prostate & Bowel Screening

Related

Sources

This guide is general information, not medical advice. Test results only make sense in context — your symptoms, examination, medicines, and previous results — and are interpreted by your treating team, who may repeat or add tests before drawing conclusions. If you have chest pain, severe breathlessness, or other emergency symptoms, seek urgent care rather than waiting for test results. PSA screening is a shared decision: whether to test at all depends on age, risk, and your own priorities after discussing the benefits and harms with your clinician.